id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-P-5787-0242,FDA,FDA-2017-P-5787,Final Response Letter from FDA CDER to Post-Finasteride Syndrome Foundation,Other,Response(s),2022-06-09T04:00:00Z,2022,6,2022-06-09T04:00:00Z,,2022-06-09T11:35:13Z,,0,0,090000648515084c